Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
- PMID: 8786327
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
Abstract
Although vigorous activated and memory CTL have been associated with HIV-1 infection, data are lacking regarding the breadth of epitopes recognized in a given individual and the relationship to the viral quasispecies present in vivo. In this study we performed a detailed analysis of the HIV-1-specific CTL response in a seropositive person with documented HIV-1 infection of 15 yr duration, stable CD4 counts above 500 cells/ml, and viral load persistently below 500 molecules of RNA/ml of plasma. Epitope mapping studies revealed the presence of HLA class I-restricted CTL responses to six different epitopes in p17, p24, RT, Env, and Nef, which conferred broadly cross-reactive recognition of reported HIV-1 variants. Sequence analysis of autologous viruses revealed the absence of immune escape variants within five of the six epitopes. Despite consistently low viral RNA levels in plasma and viral DNA levels in PBMC, in vivo-activated circulating CTL were detected against three of the epitopes. Five of the six epitopes, including the three dominant epitopes, have been detected in persons with progressive disease, suggesting that nonprogressors may not target unique epitopes. This study demonstrates that HIV-1-specific CTL can be highly activated and broadly directed in the setting of an extremely low viral load, and that neither high viral load nor antigenic diversity is required for the generation of a multispecific CTL response. Although the detection of strong CTL responses, low viral load, and lack of immune escape are consistent with the hypothesis that CTL may contribute to lack of disease progression in this individual, the contribution of these responses to maintenance of the asymptomatic state remains to be determined.
Similar articles
-
Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.J Immunol. 1998 Nov 1;161(9):4875-81. J Immunol. 1998. PMID: 9794421
-
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.J Immunol. 1996 Nov 1;157(9):4212-21. J Immunol. 1996. PMID: 8892659
-
Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.AIDS. 2008 Jul 11;22(11):1277-86. doi: 10.1097/QAD.0b013e3283021a8c. AIDS. 2008. PMID: 18580606
-
Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.Clin Sci (Lond). 1999 Dec;97(6):707-18. Clin Sci (Lond). 1999. PMID: 10585898 Review.
-
The cytotoxic T-lymphocyte response in HIV-1 infection.Clin Lab Med. 1994 Jun;14(2):271-99. Clin Lab Med. 1994. PMID: 7924192 Review.
Cited by
-
Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination.J Virol. 2003 Apr;77(8):4695-702. doi: 10.1128/jvi.77.8.4695-4702.2003. J Virol. 2003. PMID: 12663776 Free PMC article.
-
Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV.Vaccine. 2008 Jun 6;26(24):3059-71. doi: 10.1016/j.vaccine.2007.12.004. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18206276 Free PMC article.
-
Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.J Virol. 2008 Apr;82(8):4102-14. doi: 10.1128/JVI.02212-07. Epub 2008 Jan 30. J Virol. 2008. PMID: 18234797 Free PMC article.
-
Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees.J Virol. 1999 Aug;73(8):7065-9. doi: 10.1128/JVI.73.8.7065-7069.1999. J Virol. 1999. PMID: 10400811 Free PMC article.
-
Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs.J Virol. 2002 Nov;76(22):11397-404. doi: 10.1128/jvi.76.22.11397-11404.2002. J Virol. 2002. PMID: 12388700 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials